• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Laurus’s Generics Valsartan Receives Approval in US

    FDA

    Laurus’s Generics Emtricitabine Receives Approval in US

    FDA

    Laurus’s Generics Sitagliptin Receives Tentative Approval In US

    FDA

    Laurus’s Generics Macitentan Receives Approval in US

    FDA

    Laurus`s Generics Flucytosine Receives Approval in US

    FDA

    Laurus` Generic Oseltamivir Phosphate Receives Approval in the U.S.

    FDA

    Laurus` Generic Gabapentin Receives Approval in the U.S.

    FDA

    Laurus Labs` Generic Bictegravir, Emtricitabine, Tenofovir Alafenamide Receives Approval in the U.S.

    FDA

    Laurus Labs` Generic Metformin Hydrochloride Receives Approval in the U.S.

    FDA

    Laurus Labs Generic Abacavir Sulfate Receives Approval in the U.S.

    FDA

    Laurus Labs Generic Pirfenidone Receives Approval in the U.S.

    FDA

    Laurus` Generic Lopinavir & Ritonavir Receives Approval in the U.S.

    FDA

    Laurus Labs` Generic Canagliflozin Receives Approval in the U.S.

    FDA

    Laurus` Generic Efavirenz, Emtricitabine and Tenofovir Disoproxil FumarateReceives Approval in the U.S.

    FDA

    Laurus Labs Generic Abacavir; Dolutegravir;Lamivudine Receives Tentative Approval in US

    FDA

    Laurus Labs`s Generic Metformin Hydrochloride Receives Approval in US

    FDA

    Laurus Labs Generic Tenofovir Disoproxil Fumarate Receives Approval In US

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.